ReviewInternational journal of molecular sciences2026
A Mechanism-Centered Text-Mining Landscape of Mitochondrial Bioenergetics and Signaling in Disease Research.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitochondria are increasingly recognized as integrated bioenergetic and signaling hubs across disease contexts, but the rapidly expanding literature remains fragmented across mechanisms, diseases, and analytical vocabularies. This study mapped the disease-oriented literature on mitochondrial bioenergetics and signaling from 2014 to 2025 using a mechanism-centered text-mining framework integrating dictionary-based annotation and topic modeling. Records retrieved from Web of Science, Scopus, and PubMed were harmonized into a final corpus of 166,462 title-abstract records. Dictionary-based annotation was used to identify disease and mitochondrial mechanism signals, followed by disease-mechanism co-occurrence, lift-based enrichment, exploratory drug/compound annotation, non-negative matrix factorization (NMF), and structural topic modeling (STM). Publication output increased approximately 2.6-fold over the study period. The literature was organized around a central mechanistic backbone involving ROS/redox biology, cell death pathways, bioenergetics/OXPHOS, mitochondrial dysfunction/homeostasis, and quality-control processes. Cancer, cardiometabolic/metabolic disease, and neurodegeneration/neurological injury were the dominant disease contexts. Enrichment analysis revealed disease-characteristic mitochondrial signatures, while NMF identified a 20-topic thematic structure and STM showed increasing emphasis on mitochondrial dysfunction, immune-inflammatory signaling, omics-based prognostic signatures, therapeutic delivery systems, and cancer progression/resistance. Overall, mitochondrial disease research is shifting toward an integrated, application-oriented framework in which mitochondria are positioned as bioenergetic, signaling, immune-regulatory, and therapeutic-response hubs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.